Cannabist Company Holdings Inc (CBST) fair value: what the stock is really worth
As of Jun 22, 2026: fair value of Cannabist Company Holdings Inc C$0.08, price C$0.04, upside +115.0%, quality 27 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Cannabist Company Holdings Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries.
Show more
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brands. In addition, the company provides management services to licensed entities. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The Cannabist Company Holdings Inc. was founded in 2012 and is headquartered in Chelmsford, Massachusetts.
Stock analysis
Cannabist Company Holdings Inc (CBST) currently trades at C$0.0350, while our model-based Fair Value estimate is C$0.0753, implying the stock looks roughly 53.5% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 91/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 27/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Cannabist Company Holdings Inc reported revenue of $459M in FY2024 versus $189M in FY2020, a compound +24.8%/yr. Reported net income was −$106M in FY2024.
Key figures
Market cap C$16.2M (≈ $11.4M) · P/S ratio 0.05 · EPS (TTM) C$−0.5300 · Net margin −23.1% · Return on equity −596% · Return on assets (EBIT) −7.5% · Operating margin −15.1% · Revenue (TTM) $350M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).
What moves the price
The share trades about 83% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at 115%, CBST screens cheaper than that median.
Fair Value models
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.30/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−10.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+42.1%
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+231.2%
’18
’19
’20
’21
’22
’23
’24
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−121.5% (2019) → −4.9% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss
Compare Cannabist Company Holdings Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 569 stocks
Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score26 · Bottom 25%
Fair Value upside+115.1% · Top 25%
Profitability
Return on equity (TTM)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets−4.6% · Bottom 25%
Net margin (TTM)−51.2% · Bottom 25%
Operating margin (TTM)−15.1% · Bottom 25%
Growth and dividend
Revenue growth−30.4% · Bottom 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM)0.03× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)100· sector 14
FUTURE (revenue growth)0· sector 26
PAST (return on equity)0· sector 29
HEALTH (low debt)0· sector 96
DIVIDEND (yield)0· sector 30
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Cannabist Company Holdings Inc Fair Value". https://www.fairvalue-calculator.com/stock/CBST
Frequently asked questions
Is Cannabist Company Holdings Inc (CBST) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of C$0.0753 versus the last price from Jun 22, 2026 of C$0.0350, about +115% upside (undervalued).
What is the fair value of CBST?
Our model-based fair value for Cannabist Company Holdings Inc is C$0.0753 (as of Sep 13, 2026), built from audited fundamentals. Last price (from Jun 22, 2026): C$0.0350.
What is the quality score of CBST?
Cannabist Company Holdings Inc has a Quality Score of 27/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cannabist Company Holdings Inc (CBST)?
Our model-based price target is the fair value of C$0.0753 (as of Sep 13, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Cannabist Company Holdings Inc stock forecast for 2026?
Our models put fair value at C$0.0753, about +115% upside versus the last price from Jun 22, 2026 of C$0.0350 (undervalued). The calculation is refreshed regularly with new filings.
What is the revenue of Cannabist Company Holdings Inc (CBST)?
Cannabist Company Holdings Inc reported trailing-twelve-month revenue of about $350M (latest available figure, as of Sep 13, 2026).
What is the intrinsic value of Cannabist Company Holdings Inc (CBST)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cannabist Company Holdings Inc it is C$0.0753 per share (as of Sep 13, 2026), against a price of C$0.0350. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Cannabist Company Holdings Inc stock overvalued or undervalued in 2026?
As of Sep 13, 2026, CBST trades below its calculated fair value: price C$0.0350, fair value C$0.0753, a gap of about +115% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CBST?
No. The price is what the market pays today (C$0.0350); the fair value is what the company's own numbers justify (C$0.0753). For Cannabist Company Holdings Inc the two are C$0.0403 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cannabist Company Holdings Inc worth?
The market values Cannabist Company Holdings Inc at about C$16.2M (market capitalisation, as of Sep 13, 2026). Per share that is C$0.0350; our models calculate a fair value of C$0.0753 per share.
How solid is the balance sheet of Cannabist Company Holdings Inc (CBST)?
Balance-sheet figures for Cannabist Company Holdings Inc (as of Sep 13, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 27/100, which measures business quality independently of the share price.
How far is CBST from its 52-week high?
Cannabist Company Holdings Inc trades at C$0.0350, about 83% below its 52-week high of C$0.2050 and 17% above the low of C$0.0300 (as of Jun 22, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.0753 is for.
Which stocks are comparable to Cannabist Company Holdings Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cannabist Company Holdings Inc stock attractive at the current price?
The data as of Sep 13, 2026: price C$0.0350, calculated fair value C$0.0753 (+115%), Quality Score 27/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CBST calculated?
We run Cannabist Company Holdings Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of C$0.0753, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Cannabist Company Holdings Inc currently trades 53 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cannabist Company Holdings Inc (CBST)?
The latest price we hold is from Jun 22, 2026 and stands at C$0.0350. Our model-based fair value is C$0.0753, about +115% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cannabist Company Holdings Inc right now?
The large discount to fair value meets weak quality (27/100). That raises the risk this is a value trap rather than a bargain. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Cannabist Company Holdings Inc
How large is the market capitalisation of Cannabist Company Holdings Inc (CBST)?
The market capitalisation of Cannabist Company Holdings Inc is C$16.2M (≈ $11.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cannabist Company Holdings Inc (CBST)?
The price-to-sales ratio of Cannabist Company Holdings Inc is 0.05 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cannabist Company Holdings Inc (CBST)?
Earnings per share at Cannabist Company Holdings Inc are C$−0.5300. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Cannabist Company Holdings Inc (CBST)?
The net margin of Cannabist Company Holdings Inc is −23.1% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cannabist Company Holdings Inc (CBST)?
The return on equity (ROE) of Cannabist Company Holdings Inc is −596% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cannabist Company Holdings Inc (CBST)?
On an EBIT basis the return on assets of Cannabist Company Holdings Inc is −7.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cannabist Company Holdings Inc (CBST)?
The operating margin of Cannabist Company Holdings Inc is −15.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cannabist Company Holdings Inc (CBST)?
Revenue at Cannabist Company Holdings Inc is growing −30.4% versus a year earlier (3y avg +0.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Cannabist Company Holdings Inc (CBST) generate?
The free cash flow of Cannabist Company Holdings Inc is −$29.2M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Cannabist Company Holdings Inc (CBST) carry?
The net debt of Cannabist Company Holdings Inc is $445M (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Cannabist Company Holdings Inc in the live analysis
One click puts Cannabist Company Holdings Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
